Celltrion Pharm at ENA 2026
Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website
Celltrion Pharm brings 2 presentations to ENA 2026 in Barcelona. Its posters centre on antibody-drug conjugate technology. They present a dual-payload ADC platform designed to add to the effect of MMAE while reducing side effects, and CellPh-Linker Conjugation, a Fab-site selective conjugation method that needs no antibody engineering.
| Organization | ENA 2026 Attendance |
|---|---|
Celltrion Pharm Cheongju, South Korea | |
Drugmaker in the Celltrion group making chemical drugs and biosimilars, now developing antibody-drug conjugates. | Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm |
Instantly find 20 buyers from Celltrion Pharm
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction